Natfluence
"Linda Matthews Continues to Blaze Trails and Transform BioCare, Inc."
Bitbean “CEOs Speak”
We Spoke to Linda Matthews of BioCare
Authority Magazine
"Women of the C-Suite: Linda Matthews of BioCare on the Five Things You Need to Succeed As A Senior Executive"
Managed Healthcare Executive: Tuning into the C-Suite
"The Evolution of Delivering Therapy in Healthcare and How to Expand Your Healthcare Business Today"
ADMA Biologics Announces BioCareSD Selected as Primary Authorized Distributor of ASCENIV™ and First Commercial Sales
BioCareSD has been selected by ADMA Biologics, Inc. as the primary authorized national distributor for ASCENIV. ASCENIV is a plasma-derived, polyclonal human immune globulin product. ASCENIV is indicated for the treatment of Primary Humoral Immunodeficiency or Primary...
BioCareSD Selected Primary Authorized Distributor for BIVIGAM®
BioCareSD has been selected by ADMA Biologics, Inc. as the primary authorized national distributor for BIVIGAM®. BIVIGAM®[Immune Globulin Intravenous (Human), 10% Liquid] is indicated for the treatment of primary humoral immunodeficiency (PI). Linda Matthews, president of BioCareSD, said,...
Linda Matthews Named One Of The 2018 PM360 ELITE 100
PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, and medical device sectors, has named Linda Matthews, President, BioCareSD, Inc., as one of the 2018 PM360 ELITE 100 in the Transformational Leader...
BioCare to Become Separate Company January 1, 2017
Blood Systems, Incorporated has announced that the operations of BioCare, its plasma and biological therapeutics sales division, will be transferred to BioCare, Inc., a separate, for-profit subsidiary of Blood Systems, effective January 1, 2017. Blood Systems...
BioCare Selected as Exclusive Distributor for Ceprotin
Manufacturer Shire has named BioCare as the exclusive, national authorized distributor for CEPROTIN, a Protein C concentrate replacement therapy. It is indicated for the prevention and treatment of venous thrombosis and purpura fulminans for pediatric and adult...
Octapharma’s NUWIQ Available at BioCare
BioCare is excited to announce that Octapharma’s NUWIQ is now available. Nuwiq is the first and only recombinant FVIII produced in human cells without chemical modification. It is indicated in children and adults with Hemophilia A for on-demand treatment &...